Details werden geladen...
Israeli-founded AI biotech Immunai expands AstraZeneca cancer collaboration | The Jerusalem Post
The expanded agreement extends and broadens the companies’ multi-year collaboration in oncology through 2027, according to the statement.
Ähnliche Seiten
New Israeli-led AI model to predict chemotherapy benefit in breast cancer | The Jerusalem Post
https://www.jpost.com/science/article-893533A simple nutritional component may improve cancer treatment | The Jerusalem Post
https://www.jpost.com/health-and-wellness/nutrition/article-894960Israeli AI startup cracks the code of who is at fault when the system fails | The Jerusalem Post
https://www.jpost.com/business-and-innovation/tech-and-start-ups/article-894819
Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform | The Manila Times
https://www.manilatimes.net/2026/03/25/tmt-newswire/globenewswire/purple-biotech-announces-ai-collaboration-with-converge-bio-to-accelerate-development-of-its-next-generation-tri-specific-antibody-platform/2307434Israeli court extends detention of two Gaza flotilla activists | The Jerusalem Post
https://www.jpost.com/international/article-895211